In their paper, Kanner et al. demonstrated that MSLN expression could assist in differentiating Müllerian serous carcinomas from metastatic breast carcinomas (particularly those with a papillary morphology) and documented that none of the breast carcinomas were stained for MSLN [36]. This evidence concerns the gene MSLN and breast carcinoma.